Literature DB >> 2403843

Expression of CD44 confers a new adhesive phenotype on transfected cells.

T St John1, J Meyer, R Idzerda, W M Gallatin.   

Abstract

The function of the CD44 glycoprotein as an adhesion molecule was directly tested by transformation of a CD44 cDNA into mouse fibroblasts. This cDNA was expressed as a heavily modified cell surface protein reactive with monoclonal antibodies that recognize glycoproteins now identified in primates as CD44. Independent transfectants exhibited a new self-adhesive phenotype, forming large aggregates when placed in suspension. In variants derived from a clone of cells, aggregation competence segregated with expression of the transfected gene. This CD44-mediated adhesion was blocked specifically by monoclonal antibodies binding one immunologically defined region of CD44. Nontransfected L cells did not self-aggregate but were capable of adhering to the transfectants, indicating that at least one ligand for this adhesion molecule is expressed by mouse fibroblasts.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2403843     DOI: 10.1016/0092-8674(90)90714-p

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  35 in total

Review 1.  Extracellular matrix molecules and their receptors: functions in neural development.

Authors:  L F Reichardt; K J Tomaselli
Journal:  Annu Rev Neurosci       Date:  1991       Impact factor: 12.449

2.  Detachment of transformed cells. Role of CD44 variants.

Authors:  C Santos; K Chandler; S Zimmer; P B Fisher; U Gunthert; K W Anderson
Journal:  Cell Biophys       Date:  1995-02

3.  CD44-related chondroitin sulfate proteoglycan, a cell surface receptor implicated with tumor cell invasion, mediates endothelial cell migration on fibrinogen and invasion into a fibrin matrix.

Authors:  C A Henke; U Roongta; D J Mickelson; J R Knutson; J B McCarthy
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

4.  Molecular mechanisms regulating the hyaluronan binding activity of the adhesion protein CD44.

Authors:  R K Chiu; A Droll; D L Cooper; S T Dougherty; J F Dirks; G J Dougherty
Journal:  J Neurooncol       Date:  1995-12       Impact factor: 4.130

Review 5.  Adhesion molecules in lymphoma metastasis.

Authors:  E Roos
Journal:  Cancer Metastasis Rev       Date:  1991-05       Impact factor: 9.264

6.  Splicing choice from ten variant exons establishes CD44 variability.

Authors:  C Tölg; M Hofmann; P Herrlich; H Ponta
Journal:  Nucleic Acids Res       Date:  1993-03-11       Impact factor: 16.971

7.  Expression of CD44 is repressed in neuroblastoma cells.

Authors:  E Shtivelman; J M Bishop
Journal:  Mol Cell Biol       Date:  1991-11       Impact factor: 4.272

Review 8.  Barrier immunity and IL-17.

Authors:  Benjamin R Marks; Joe Craft
Journal:  Semin Immunol       Date:  2009-04-21       Impact factor: 11.130

Review 9.  CD44: physiological expression of distinct isoforms as evidence for organ-specific metastasis formation.

Authors:  M Zöller
Journal:  J Mol Med (Berl)       Date:  1995-09       Impact factor: 4.599

10.  Expression of the CD44 variant isoforms 6 and 4/5 in breast cancer. Correlation with established prognostic parameters.

Authors:  P A Regidor; R Callies; M Regidor; U Günthert; M Zöller; A E Schindler
Journal:  Arch Gynecol Obstet       Date:  1996       Impact factor: 2.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.